Business
AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023
VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) will announce its first quarter 2023 financial results on Thursday, May 4, 2023, and
About this update from Abcellera Biologics Inc.
[{"type":"text","content":" VANCOUVER, British Columbia--(BUSINESS WIRE)--\nAbCellera (Nasdaq: ABCL) will announce its first quarter 2023 financial results on Thursday, May 4, 2023, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.\n\n\nA live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the conference call.\n\n\nAbout AbCellera Biologics Inc.\n\n\nAbCellera is breaking the barriers of conventional antibody drug discovery to bring better medicines to patients, sooner. AbCellera’s engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to clinic in nearly every therapeutic area with precision and speed. AbCellera provides innovative biotechs and leading pharmaceutical companies with a competitive advantage that empowers them to move quickly, reduce cost, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20230404006025/en/\n\nInquiries\nMedia: Jessica Yingling, Ph.D.; [email protected], +1(236)521-6774\nBusiness Development: Murray McCutcheon, Ph.D.; [email protected], +1(604)559-9005\nInvestor Relations: Josephine Hellschlienger, Ph.D.; [email protected], +1(778)729-9116\n\n\nSource: AbCellera Biologics Inc.","length":3323,"tagName":"div"}]